A decision-making process to guide the potential application of a hepatitis A virus and parvovirus B19 nucleic acid test for qualifying plasma for fractionation
Leisa Bruneau(Canadian Blood Services), Steven J. Drews(University of Alberta), Carmen Charlton(University of Alberta), Gordon Hawes(Canadian Blood Services), Elaine Tang(Canadian Blood Services), Mark Bigham(Canadian Blood Services)
Journal of the Association of Medical Microbiology and Infectious Disease Canada
May 11, 2026
Cited by 0
Related Papers
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
|Clinical Infectious Diseases|2016|232
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections
|Clinical Microbiology Reviews|2018|190
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015
|The Journal of Infectious Diseases|2017|170
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
|Vaccine|2013|159
Effectiveness of pertussis vaccination and duration of immunity
|Canadian Medical Association Journal|2016|139